4.7 Article

The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study

Vincenzo Russo et al.

Summary: This study compares device-related complications, infections, and inappropriate therapies between drug-induced type 1 Brugada Syndrome patients with transvenous-ICD (TV-ICD) and subcutaneous-ICD (S-ICD). The results show that there were no significant differences between S-ICD and TV-ICD in terms of inappropriate ICD therapies, device-related complications, and infections. However, the S-ICD group had a trend towards reduced lead-related complications.

HEART AND VESSELS (2023)

Article Urology & Nephrology

Incidence and risk factors for acute kidney injury in patients with cardiac implantable electronic devices undergoing transvenous lead removal

Christoph Edlinger et al.

Summary: This study aimed to investigate the incidence and potentially modifiable risk factors of acute kidney injury (AKI) in patients with cardiac implantable electronic devices (CIED) undergoing lead removal. The study found that nearly a quarter of patients developed AKI after the procedure, and identified defibrillator lead type, necessity for laser-assisted lead removal, and time from initial implantation to lead removal as independent risk factors for AKI. AKI was also associated with in-hospital mortality.

CLINICAL NEPHROLOGY (2022)

Article Cardiac & Cardiovascular Systems

Patient acceptance of subcutaneous versus transvenous defibrillator systems: A multi-center experience

Alessandro Vicentini et al.

Summary: The study evaluated patient acceptance of the S-ICD and found varying levels of acceptance among different demographics, with younger patients and those who experienced device complications or therapies showing better acceptance. Despite these differences, overall patient acceptance of the S-ICD was positive, with S-ICD showing better positive appraisal compared to transvenous ICD in patients with HFrEF.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry

Vincenzo Russo et al.

Summary: This study aims to investigate the clinical features and treatment outcomes of patients with S-ICD and T-ICD in a randomized clinical trial. The results showed that S-ICD had a lower risk of infections and non-infectious complications compared to T-ICD in patients who require defibrillator therapy but not pacing.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Inappropriate shocks due to air entrapment in patients with subcutaneous implantable cardioverter-defibrillator: A meta-summary of case reports

Michele Iavarone et al.

Summary: The study found that air entrapment is an early complication of S-ICD implantation leading to inappropriate shocks. Patients experienced symptoms within 4 days post-implantation, with subcutaneous air mainly observed through chest x-ray. Treatment options include reprogramming sensing vectors or turning off the ICD device.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

Michael R. Gold et al.

Summary: The UNTOUCHED trial evaluated the efficacy and safety of contemporary S-ICD devices in a more typical, contemporary ICD patient population, demonstrating high freedom from IAS and shock rates. The study found a 18-month freedom from IAS of 95.9% and all-cause shock-free rate meeting the prespecified performance goal.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction

Vincenzo Russo et al.

Summary: The study compared outcomes of patients who underwent lead abandonment and S-ICD implantation with those who underwent extraction and subsequent reimplantation of T-ICD after lead malfunction. Results showed 3 major complications or deaths in the S-ICD group and 11 in the T-ICD group during a median follow-up of 21 months. Minor complications were 4 in the S-ICD group and 5 in the T-ICD group.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis

Roberto Rordorf et al.

Summary: Comparison between S-ICD and TV-ICD in terms of clinically relevant device-related complications and inappropriate shocks found that the two are overall comparable. Patients with S-ICD had lower risk of lead complications and major procedural complications compared to those with TV-ICD, but higher risk of pocket complications.

HEART RHYTHM (2021)

Article Cardiac & Cardiovascular Systems

Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator

Gavino Casu et al.

Summary: In patients with Brugada syndrome using subcutaneous implantable cardioverter defibrillators (S-ICDs), inappropriate shocks (IS) are a frequent and adverse complication. Younger age is independently associated with IS, suggesting that a more thorough screening process may help prevent IS in this population.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience

Alessio Gasperetti et al.

Summary: The study aimed to evaluate device-related complications in a large real-world multicenter S-ICD cohort. Over 23.2 months of follow-up, the overall complication rate was 9.3%. Early unanticipated device battery depletions occurred in 2.2% of patients, while lead fracture was observed in 0.3%.

HEART RHYTHM (2021)

Article Cardiac & Cardiovascular Systems

Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center

Erik Oosterwerff et al.

Summary: The study evaluated the efficacy and safety of the subcutaneous cardioverter-defibrillator (S-ICD) in patients with different types of cardiomyopathies, revealing that patients with ischemic cardiomyopathy had significantly less inappropriate therapy and were more suitable for S-ICD implantation.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome

Vincenzo Russo et al.

Summary: Drug-induced type 1 BrS patients have a very low arrhythmic risk, and the decision for ICD implantation is supported by syncope and/or EPS positivity, although these methods fail to effectively identify high-risk patients.

JACC-CLINICAL ELECTROPHYSIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators

Sajya M. Singh et al.

Summary: A high prevalence of generalized anxiety was identified among inherited channelopathy patients with ICDs. Most patients demonstrated high device acceptance, and there was lack of association with ICD shocks or complications. Further research is necessary to understand this increased incidence.

HEART RHYTHM O2 (2021)

Review Cardiac & Cardiovascular Systems

An overview of cycling as active transportation and as benefit for health

Mariangela Peruzzi et al.

MINERVA CARDIOANGIOLOGICA (2020)

Article Cardiac & Cardiovascular Systems

Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping

Larry M. Baddour et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2020)

Article Medicine, General & Internal

Subcutaneous or Transvenous Defibrillator Therapy

Reinoud E. Knops et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome

Ibrahim El-Battrawy et al.

CLINICAL RESEARCH IN CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort

Hein Heidbuchel et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Quality of life, depression, and anxiety in patients with a subcutaneous versus transvenous defibrillator system

Susanne S. Pedersen et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Body image concerns in patients with an implantable cardioverter defibrillator: A scoping review

Vivi S. Frydensberg et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2018)

Article Health Care Sciences & Services

Incidence and costs of cardiac device infections: retrospective analysis using German health claims data

Saskia Ludwig et al.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2018)

Article Cardiac & Cardiovascular Systems

Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems

Julia Koebe et al.

CLINICAL RESEARCH IN CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Cardiac implantable electronic device infections: Who is at greatest risk?

Parijat Saurav Joy et al.

HEART RHYTHM (2017)

Article Cardiac & Cardiovascular Systems

Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry The EFFORTLESS Study

Lucas Boersma et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy

Alessandro Paoletti Perini et al.

AMERICAN HEART JOURNAL (2017)

Article Cardiac & Cardiovascular Systems

2016 European Guidelines on cardiovascular disease prevention in clinical practice

Massimo F. Piepoli et al.

EUROPEAN HEART JOURNAL (2016)

Article Sport Sciences

Athletes with Implantable Cardioverter Defibrillators

Shiva P. Ponamgi et al.

CLINICS IN SPORTS MEDICINE (2015)

Article Cardiac & Cardiovascular Systems

A New Algorithm to Reduce Inappropriate Therapy in the S-ICD System

Amy J. Brisben et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac Death

Agnes J. Verkerk et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Increased Long-Term Mortality in Patients with Cardiovascular Implantable Electronic Device Infections

Muhammad Rizwan Sohail et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

Pier D. Lambiase et al.

EUROPEAN HEART JOURNAL (2014)

Article Cardiac & Cardiovascular Systems

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

Raul Weiss et al.

CIRCULATION (2013)

Article Cardiac & Cardiovascular Systems

Shock Efficacy of Subcutaneous Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death Initial Multicenter Experience

Ali Aydin et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2012)

Article Cardiac & Cardiovascular Systems

16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States 1993 to 2008

Arnold J. Greenspon et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Editorial Material Cardiac & Cardiovascular Systems

Implantable cardioverter-defibrillator lead performance

William H. Maisel et al.

CIRCULATION (2008)

Review Cardiac & Cardiovascular Systems

Quality of death: Implantable cardioverter defibrillators and proactive care

SF Sears et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Quality of life in implanted cardioverter defibrillator recipients: The impact of a device shock

DL Carroll et al.

HEART & LUNG (2005)